Human leukocyte antigen DR15 is associated with reduced relapse rate and improved survival after human leukocyte antigen-identical sibling hematopoietic stem cell transplantation. [electronic resource]
Producer: 20070123Description: 1169-75 p. digitalISSN:- 1083-8791
- Cohort Studies
- Graft vs Host Disease -- immunology
- Graft vs Leukemia Effect -- immunology
- HLA-DR Antigens -- immunology
- HLA-DR Serological Subtypes
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Kaplan-Meier Estimate
- Leukemia -- therapy
- Lymphoma, Non-Hodgkin -- therapy
- Predictive Value of Tests
- Prognosis
- Retrospective Studies
- Secondary Prevention
- Siblings
- Transplantation, Isogeneic -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.